https://www.selleckchem.com/pr....oducts/Temsirolimus.
This study was designed to evaluate the effectiveness of a yoga-based exercise program (YBEP) in improving glycemic control in people with type 2 diabetes mellitus. Patients on stable oral glucose-lowering agents for at least 3 months and HbA1c 7.5%-10% were randomized in 11 ratio. The primary outcome measure was the difference of change in mean HbA1c between groups. The participants ( = 81) had mean (±standard deviation) age of 50.6 (±8.5) years and HbA1c of 8.5 ± 0.7% (68.97 ± 7.42 mmol/mol). The follow-up data were available in